Specialty and Weight Loss
Hear how weight loss drugs are shaping traditional and specialty spend with Optum Rx chief pharmacy officer, Mike Einodshofer. Learn about trends and outlook.
Biosimilars to save billions in this decade
Prices for popular brand-name biologics drop up to 60% with generic-equivalent biosimilars.
3 new first-in-class therapies coming
See how innovation is driving the latest product development.
Unlocking the future of specialty innovation
Optum Specialty Compass
See how our personalized specialty expertise and custom analytics platform helps clients find the right solutions to reduce specialty trend.
Carving out specialty pharmacy
By integrating specialty management, clients can lower their spend by up to $16 PMPM.